- Home
- SPCE vs TIL Comparison
SPCE vs TIL Comparison
Compare SPCE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | TIL |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.9M | 177.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPCE | TIL |
|---|---|---|
| Price | $3.25 | $10.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $9.22 | ★ $100.67 |
| AVG Volume (30 Days) | ★ 3.8M | 69.7K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,661,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,656.89 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $10.70 |
| 52 Week High | $6.82 | $42.79 |
Technical Indicators
Market Signals| Indicator | SPCE | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 39.43 | 36.08 |
| Support Level | $3.71 | $10.76 |
| Resistance Level | $4.57 | $11.51 |
| Average True Range (ATR) | 0.26 | 0.73 |
| MACD | -0.05 | 0.16 |
| Stochastic Oscillator | 4.01 | 2.71 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.